Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age group from 18 to 65 years ASA I and ASA II Elective surgeries under general anaesthesia
Exclusion criteria
Exclusion criteria: Patient refusal to participate in the study Patients taking magnesium supplements Patients with arrhythmias Patients with neuromuscular diseases Patients on beta blockers or antiarrhythmic drugs Patients using medications that influence neuromuscular functions (e.g., calcium channel blockers, phenytoin, aminoglycosides) Electrolytes abnormalities Hepatic or renal insufficiency Pregnant and breastfeeding women Patients with known allergies to medications used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the ideal intubation conditions of two different ED95 doses (3ED95 Vs 6ED95) of Cisatracurium with Magnesium SulphateTimepoint: 3 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the ease of intubation Duration of action of intubating dose Total dose of Cisatracurium used in each group Hemodynamics ComplicationsTimepoint: 5 minutes | — |
Countries
India
Contacts
Aarupadai veedu medical college and hospital.